BRANFORD, Conn., July 5 /PRNewswire-FirstCall/ -- CAS Medical Systems, Inc. , a medical device company focused on innovative non-invasive vital signs monitoring, today announced that it has been awarded two United States Patents for technology used in its FORE-SIGHT(TM) Cerebral Oximeter, which is scheduled for commercial release in late 2006.
The patents represent several years of research and development focused on bringing to market a non-invasive, commercially viable technology that allows clinicians to monitor absolute levels of oxygen saturation in the brain. The new patents (U.S. Patent 7,047,054 and U.S. Patent 7,072,701) cover aspects of the FORE-SIGHT patient sensor design and laser safety system, as well as the algorithm method used by the FORE-SIGHT device to allow for an absolute measurement.
“Our research and development team has made great strides in the development of this device, and the receipt of two more patents for technology used in FORE-SIGHT is an important milestone and highlights our strong IP position,” stated Louis P. Scheps, President and CEO of CAS Medical. “Our goal is to continue to pursue the issuance of patents to enable us to maximize the value of the innovative technology used in this compelling device. We believe that our recent achievements, in combination with the launch of the FORE-SIGHT product at the end of this year, will continue to propel the company’s future growth.”
About the FORE-SIGHT Cerebral Oximeter
About 700,000 high risk cardiovascular surgeries are performed each year in the United States. Protecting the brain from low oxygen levels during these procedures is an important goal of every surgical team because the brain is highly vulnerable to oxygen deprivation. At normal body temperatures, damage to brain cells due to lack of oxygen can occur after just a few seconds. The FORE-SIGHT Cerebral Oximeter provides new information that allows clinicians to monitor and quickly respond to instances of brain tissue oxygen deprivation before damage to the brain occurs.
About CAS Medical Systems, Inc. Founded in 1984, CAS Medical Systems, Inc. (CASMED (TM)) is dedicated to the design and manufacture of innovative technologies and products vital to patient care in the most challenging clinical environments. Its current product lines include blood pressure measurement technology, vital signs monitoring equipment, blood pressure cuffs, apnea monitoring equipment and products for neonatal intensive care. With a reputation for the highest quality products available in the markets it serves, CASMED products are used by clinicians worldwide.
For more information contact: ir@casmed.com Investors Media Financial Dynamics Financial Dynamics John Capodanno Robert Stanislaro 212-850-5705 212-850-5657 jcapodanno@fd-us.comrstanislaro@fd-us.com
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future financial performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, and other risks detailed in the Company’s Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms “anticipate,” “believe,” “estimate,” “expect,” “may,” “objective,” “plan,” “possible,” “potential,” “project,” “will” and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward- looking statements, whether as a result of future events, new information or otherwise.
CAS Medical Systems, Inc
CONTACT: Investors, John Capodanno of Financial Dynamics, +1-212-850-5705, or jcapodanno@fd-us.com , or Media, Robert Stanislaro of FinancialDynamics, +1-212-850-5657, or rstanislaro@fd-us.com , both for CAS MedicalSystems, Inc.
Web site: http://www.casmed.com/
